Pharma-Bio Serv (PBSV) Cash from Financing Activities (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Cash from Financing Activities of -$1.7 million for Q2 2026, up 1.08% year-over-year from -$1.7 million in Q2 2025, and down 102121.06% on a QoQ basis from -$1681.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$1.7 million for Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at -$1.7 million, up 1.08% year-over-year; the trailing twelve-month figure through Apr 2026 was -$1.7 million (changed 0.27% YoY), and the FY2025 annual result was -$1.8 million, down 1.03% from the prior year.
- Cash from Financing Activities came in at -$1.7 million for Q2 2026 at Pharma-Bio Serv, down from -$1681.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of -$792.0 in Q4 2023 to a low of -$1.8 million in Q1 2022.
- A 5-year average of -$699441.8 and a median of -$9202.0 in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities plunged 62248.3% in 2022 and surged 66.71% in 2023, its largest moves.
- Over 5 years, Cash from Financing Activities stood at -$2379.0 in 2022, then soared by 66.71% to -$792.0 in 2023, then sank by 120.58% to -$1747.0 in 2024, then slumped by 426.73% to -$9202.0 in 2025, then plunged by 18573.51% to -$1.7 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.7 million (Q2 2026), -$1681.0 (Q1 2026), and -$9202.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | -70.02 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -137.18 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -112.85 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -8.42 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -93.16 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 13.46 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -10.67 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 2.39 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.72 Mn |
| Apr 30, 2026 | -1.72 Mn |
| Jan 31, 2026 | -1,681.00 |
| Jan 31, 2026 | -1,681.00 |
| Oct 31, 2025 | -9,202.00 |
| Oct 31, 2025 | -9,202.00 |
| Jul 31, 2025 | -5,004.00 |
| Jul 31, 2025 | -5,004.00 |
| Apr 30, 2025 | -1.74 Mn |
| Apr 30, 2025 | -1.74 Mn |
| Jul 31, 2024 | -1,747.00 |
| Jul 31, 2024 | -1,747.00 |
| Apr 30, 2024 | -1.72 Mn |
| Apr 30, 2024 | -1.72 Mn |
| Jan 31, 2024 | -7,193.00 |
| Jan 31, 2024 | -7,193.00 |
| Oct 31, 2023 | -792.00 |
| Oct 31, 2023 | -792.00 |
| Jul 31, 2023 | -5,083.00 |
| Jul 31, 2023 | -5,083.00 |